We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




First Meeting of Nanomedicine Society

By Biotechdaily staff writers
Posted on 24 Aug 2005
The American Academy of Nanomedicine (AANM, Washington, DC, USA) held its first annual meeting at Johns Hopkins University (Baltimore, MD, USA) on August 15 and 16, 2005.

Founded in early 2005, the AANM is an international society created to advance both clinical applications and research in the field of nanomedicine. More...
The two-day program focused on the applications of nanomedicine in a variety of fields including diagnostic, clinical, oncology, pharmacology, basic and experimental nanomedicine, and the policy and commercialization of nanomedicine.

The keynote speaker was James Baker, Jr., M.D., from the Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan (Ann Arbor, USA), who lectured on "What is Nanomedicine?” He further described how nanoscale synthetic materials with biologic systems provide both great promises and risks for biologic sciences.

The second address was given by Dr. Ueli Aebi from the U.S. National Center of Competence in Research, Mueller Institute (Basel, Switzerland), in a lecture entitled "Imaging, Measuring, and Manipulating Living Matter by Minimally Invasive Nanoprobes.”

AANM's membership represents basic and clinical investigators, molecular biologists, engineers, physicians, and others with an interest in the field. It is the only society devoted specifically to the emerging field of nanomedicine. The Academy's first meeting provided a forum to exchange ideas, communicate new findings, and encouraged collaboration among the diverse disciplines represented in nanomedicine.




Related Links:
American Academy of Nanomedicine

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Multi-Chamber Washer-Disinfector
WD 390
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.